Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

The many faces of B regulatory cells.

Vadasz Z, Toubi E.

Isr Med Assoc J. 2014 Oct;16(10):631-3. No abstract available.

PMID:
25507969
[PubMed - in process]
Free Article
2.

New potential biomarkers for disease activity and fibrosis in systemic sclerosis.

Vadasz Z, Rimar D.

Isr Med Assoc J. 2014 Oct;16(10):629-30. No abstract available.

PMID:
25507968
[PubMed - in process]
Free Article
3.

The many faces of B regulatory cells.

Vadasz Z, Toubi E.

Isr Med Assoc J. 2014 Oct;16(10):631-3. No abstract available.

PMID:
25438452
[PubMed - in process]
Free Article
4.

New potential biomarkers for disease activity and fibrosis in systemic sclerosis.

Vadasz Z, Rimar D.

Isr Med Assoc J. 2014 Oct;16(10):629-30. No abstract available.

PMID:
25438451
[PubMed - in process]
Free Article
5.

The role of B regulatory cells and Semaphorin3A in atopic diseases.

Vadasz Z, Haj T, Toubi E.

Int Arch Allergy Immunol. 2014;163(4):245-51. doi: 10.1159/000360477. Epub 2014 Apr 2. Review.

PMID:
24713604
[PubMed - indexed for MEDLINE]
6.

Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.

Rimar D, Rosner I, Nov Y, Slobodin G, Rozenbaum M, Halasz K, Haj T, Jiries N, Kaly L, Boulman N, Daood R, Vadasz Z.

Arthritis Rheumatol. 2014 Mar;66(3):726-30. doi: 10.1002/art.38277.

PMID:
24574233
[PubMed - indexed for MEDLINE]
7.

A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.

Vadasz Z, Haj T, Balbir A, Peri R, Rosner I, Slobodin G, Kessel A, Toubi E.

Semin Arthritis Rheum. 2014 Jun;43(6):767-71. doi: 10.1016/j.semarthrit.2013.11.010. Epub 2013 Dec 4.

PMID:
24461079
[PubMed - in process]
8.

Cogan syndrome--pathogenesis, clinical variants and treatment approaches.

Kessel A, Vadasz Z, Toubi E.

Autoimmun Rev. 2014 Apr-May;13(4-5):351-4. doi: 10.1016/j.autrev.2014.01.002. Epub 2014 Jan 10. Review.

PMID:
24418297
[PubMed - indexed for MEDLINE]
9.

[Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012].

Vadasz Z, Toubi E.

Harefuah. 2013 May;152(5):304-6. Hebrew. No abstract available.

PMID:
23885457
[PubMed - indexed for MEDLINE]
10.

B-regulatory cells in autoimmunity and immune mediated inflammation.

Vadasz Z, Haj T, Kessel A, Toubi E.

FEBS Lett. 2013 Jun 27;587(13):2074-8. doi: 10.1016/j.febslet.2013.05.023. Epub 2013 May 22. Review.

PMID:
23707422
[PubMed - indexed for MEDLINE]
Free Article
11.

Autoimmunity and novel therapies in immune-mediated thrombocytopenia.

Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z.

Semin Hematol. 2013 Jan;50 Suppl 1:S100-8. doi: 10.1053/j.seminhematol.2013.03.015. Review.

PMID:
23664506
[PubMed - indexed for MEDLINE]
Free Article
12.

Age-related autoimmunity.

Vadasz Z, Haj T, Kessel A, Toubi E.

BMC Med. 2013 Apr 4;11:94. doi: 10.1186/1741-7015-11-94.

PMID:
23556986
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.

Tadmor T, Bejar J, Attias D, Mischenko E, Sabo E, Neufeld G, Vadasz Z.

Am J Hematol. 2013 May;88(5):355-8. doi: 10.1002/ajh.23409. Epub 2013 Mar 12.

PMID:
23494965
[PubMed - indexed for MEDLINE]
14.

Semaphorins: their dual role in regulating immune-mediated diseases.

Vadasz Z, Toubi E.

Clin Rev Allergy Immunol. 2014 Aug;47(1):17-25. doi: 10.1007/s12016-013-8360-4.

PMID:
23397481
[PubMed - in process]
15.

The Eighth International Congress on Autoimmunity.

Vadasz Z, Toubi E.

Isr Med Assoc J. 2012 Jul;14(7):459-64. No abstract available.

PMID:
22953628
[PubMed - indexed for MEDLINE]
Free Article
16.

Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.

Vadasz Z, Toubi E.

Lupus. 2012 Oct;21(12):1266-70. Epub 2012 Aug 8. Review.

PMID:
22875653
[PubMed - indexed for MEDLINE]
17.

Toll-like receptor-4 expression in infants with pertussis infection.

Vadasz Z, Bamberger E, Ben-Tikva K, Feterman M, Srugo I, Kessel A.

Infection. 2013 Feb;41(1):195-8. doi: 10.1007/s15010-012-0288-8. Epub 2012 Jul 3.

PMID:
22753132
[PubMed - indexed for MEDLINE]
18.

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.

Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E.

Arthritis Res Ther. 2012 Jun 14;14(3):R146. doi: 10.1186/ar3881.

PMID:
22697500
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Wilms' tumor gene 1: a possible new proangiogenic factor in Hodgkin lymphoma.

Vadasz Z, Shasha-Lavsky H, Nov Y, Bejar J, Lurie M, Tadmor T, Attias D.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):177-80. doi: 10.1097/PAI.0b013e318259852a.

PMID:
22688351
[PubMed - indexed for MEDLINE]
20.

[IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases].

Yehudai D, Vadasz Z.

Harefuah. 2012 Mar;151(3):171-4, 188. Review. Hebrew.

PMID:
22519268
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk